JohnRobertHyngstromMD

PubMed

• Single-Photon Emission Computed Tomography/Computed Tomography Utilization for Extremity Melanomas at a High-Volume Center.
  Fastner, S., Polly Creveling, Nathan Shen, Joshua J Horns, Tawnya L Bowles, John Hyngstrom, Elliot A Asare, Suzanne Fastner> ;The Journal of Surgical Research. 2024 Apr 1
• Lower frequencies of circulating suppressive regulatory T cells and higher frequencies of CD4naïve T cells at baseline are associated with severe immune-related advers...
  Kovacsovics-Bankowski, M., Sweere, J., Healy, C., Sigal, N., Cheng, L., Chronister, W., Evans, S., Marsiglio, J., Gibson, B., Swami, U., Erickson-Wayman, A., McPherson...> ;Journal for Immunotherapy of Cancer. 2024 Jan 17
• 1 citations
  Final 5-Year Follow-Up Results Evaluating Neoadjuvant Talimogene Laherparepvec Plus Surgery in Advanced Melanoma: A Randomized Clinical Trial.
  Reinhard Dummer, David E Gyorki, John R Hyngstrom, Meng Ning, Tatiana Lawrence, Merrick I Ross> ;JAMA Oncology. 2023 Oct 1
• Anorectal melanoma.
  Tina J Hieken, Robert R McWilliams, John Hyngstrom, Fastner, S., Suzanne Fastner> ;Journal of Surgical Oncology. 2023 Sep 1
• Regarding: Predicting Regional Lymph Node Recurrence in The Modern Age of Tumor-Positive Sentinel Node Melanoma.
  John F Thompson, John Hyngstrom, Corrado Caracò, Jonathan S Zager, Tiina Jahkola, Tawnya L Bowles, Elisabetta Pennacchioli, Harald J Hoekstra, Marc Moncrieff, Christia...> ;Annals of Surgical Oncology. 2023 Jul 1
• 3 citations
  Feasibility of personalized circulating tumor DNA detection in stage II and III melanoma.
  Elise K Brunsgaard, Tawnya L Bowles, Elliot A Asare, Kenneth Grossmann, Kenneth M Boucher, Allie Grossmann, Julie A Jackson, David A Wada, Richa Rathore, Griffin Budde...> ;Melanoma Research. 2023 Jun 1
• 2 citations
  Divergent clinical outcomes in a phase 2B trial of the TLPLDC vaccine in preventing melanoma recurrence and the impact of dendritic cell collection methodology: a rand...
  Adams, A., Carpenter, E., Clifton, G., Vreeland, T., Chick, R., O'Shea, A., McCarthy, P., Kemp Bohan, P., Hickerson, A., Valdera, F., Tiwari, A., Hale, D., Hyngstrom, ...> ;Cancer Immunology, Immunotherapy. 2023 Mar 1
• 53 citations
  Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma.
  Jason A Chesney, Antoni Ribas, Georgina V Long, John M Kirkwood, Reinhard Dummer, Igor Puzanov, Christoph Hoeller, Thomas F Gajewski, Ralf Gutzmer, Piotr Rutkowski, Le...> ;Journal of Clinical Oncology. 2023 Jan 20
• 1 citations
  A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome.
  John Marsiglio, Jordan P McPherson, Magdalena Kovacsovics-Bankowski, Joanne Jeter, Christos Vaklavas, Umang Swami, Douglas Grossmann, Alyssa Erickson-Wayman, Heloisa P...> ;Frontiers in Immunology. 2023 Jan 1
• 5 citations
  Intratumoral oncolytic virus V937 plus ipilimumab in patients with advanced melanoma: the phase 1b MITCI study.
  Brendan D Curti, Jon Richards, John R Hyngstrom, Gregory A Daniels, Mark Faries, Lynn Feun, Kim A Margolin, Sigrun Hallmeyer, Mark Grose, Yiwei Zhang, Anlong Li, Rober...> ;Journal for Immunotherapy of Cancer. 2022 Dec 1
• 2 citations
  Ageing and endothelium-mediated vascular dysfunction: the role of the NADPH oxidases.
  Oh Sung Kwon, Sung Gi Noh, Soung Hun Park, Robert H I Andtbacka, John R Hyngstrom, Russell S Richardson> ;The Journal of Physiology. 2023 Feb 1
• 17 citations
  Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial.
  , Crystal, J., Thompson, J., Hyngstrom, J., Caracò, C., Zager, J., Jahkola, T., Bowles, T., Pennacchioli, E., Beitsch, P., Hoekstra, H., Moncrieff, M., Ingvar, C., van...> ;JAMA Surgery. 2022 Sep 1
• 49 citations
  Neoadjuvant talimogene laherparepvec plus surgery versus surgery alone for resectable stage IIIB–IVM1a melanoma: a randomized, open-label, phase 2 trial
  Reinhard Dummer, David E. Gyorki, John R. Hyngstrom, Adam C. Berger, Robert M. Conry, L. Demidov, Anjali Sharma, Sheryl Treichel, Hoi-Shen Radcliffe, Kevin S. Gorski, ...> ;Nature Medicine. 2021 Oct 4
• 6 citations
  Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence.
  Craig L. Slingluff, Karl D. Lewis, Robert H.I. Andtbacka, John R. Hyngstrom, Mohammed M. Milhem, Svetomir N. Markovic, Tawnya L. Bowles, Omid Hamid, Leonel Hernandez-A...> ;Journal for Immunotherapy of Cancer. 2021 Oct 1
• 2 citations
  Safety and efficacy of autologous tumor lysate particle-loaded dendritic cell vaccination in combination with systemic therapies in patients with recurrent and metasta...
  Adams, A., Chick, R., Vreeland, T., Clifton, G., Hale, D., McCarthy, P., O'Shea, A., Bohan, P., Hickerson, A., Park, H., Sloan, A., Hyngstrom, J., Berger, A., Jakub, J...> ;Melanoma Research. 2021 Aug 1
• 8 citations
  "I need to have a fulfilling job": A qualitative study of surgeon well-being and professional fulfillment.
  Heather R. Walker, Ethan Evans, Raminder Nirula, John R. Hyngstrom, Cindy B. Matsen, Edward W. Nelson, Bartley Pickron, Ellie Zurbuchen, Ellen Morrow> ;American Journal of Surgery. 2021 Jul 21
• 6 citations
  Multi-institutional, prospective, randomized, double-blind, placebo-controlled phase IIb trial of the tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine to...
  , , , , , , , , , , , , , , , , , > ;Cancer Medicine. 2021 May 12
• 6 citations
  Trends in the management of anorectal melanoma: A multi-institutional retrospective study and review of the world literature
  Josh Bleicher, Jessica N. Cohan, William Peche, T Bartley Pickron, Courtney L. Scaife, Tawnya L. Bowles, John R. Hyngstrom, Elliot A. Asare> ;World Journal of Gastroenterology. 2021 Jan 21
• 20 citations
  Recurrence patterns in patients with Stage II melanoma: The evolving role of routine imaging for surveillance
  Josh Bleicher, Douglas S. Swords, Meghan E Mali, Lauren McGuire, Maranda K Pahlkotter, Elliot A. Asare, Tawnya L. Bowles, John R. Hyngstrom> ;Journal of Surgical Oncology. 2020 Dec 1
• 6 citations
  Oncologic outcomes of patients with Merkel Cell Carcinoma (MCC): A multi-institutional cohort study.
  Josh Bleicher, Elliot A. Asare, Shadai Flores, Tawnya L. Bowles, Glen M. Bowen, John R. Hyngstrom> ;American Journal of Surgery. 2021 Apr 1
• 55 citations
  Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit
  Douglas Grossman, Nwanneka Okwundu, Edmund K. Bartlett, Michael A. Marchetti, Megan Othus, Daniel G. Coit, Rebecca I. Hartman, Sancy A. Leachman, Elizabeth G. Berry, L...> ;JAMA Dermatology. 2020 Sep 1
• 3 citations
  Comparative effectiveness of second-line ipilimumab vs. nivolumab in combination with ipilimumab in patients with advanced melanoma who received frontline anti-PD-1 an...
  Kelsey Baron, Justin C. Moser, Shiven B. Patel, Kenneth F. Grossmann, Sarah Colonna, John R. Hyngstrom> ;Journal of Oncology Pharmacy Practice. 2021 Apr 1
• 11 citations
  Vasodilatory and vascular mitochondrial respiratory function with advancing age: evidence of a free radically mediated link in the human vasculature
  Soung Hun Park, Oh Sung Kwon, Song-Young Park, Joshua C. Weavil, Jay R. Hydren, Van Reese, Robert H.I. Andtbacka, John R. Hyngstrom, Russell S. Richardson> ;American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 2020 Feb 5
• 18 citations
  Comparative-effectiveness of pembrolizumab vs. nivolumab for patients with metastatic melanoma
  Justin C. Moser, Guo Wei, Sarah Colonna, Kenneth F. Grossmann, Shiven B. Patel, John R. Hyngstrom> ;Acta Oncologica. 2020 Jan 10
• 6 citations
  Use of the Pigmented Lesion Assay to rapidly screen a patient with numerous clinically atypical pigmented lesions.
  Aatman Shah, John R. Hyngstrom, Scott R. Florell, Douglas Grossman> ;JAAD Case Reports. 2019 Dec 1
• Join now to see all